Wen Lu

Dr. Wen Lu

Xi'an Jiaotong University, Xi’an, Shaanxi, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2022 in Topics in Current Chemistry
Verified
Journal Article
Closed access
PDF file
YLYanchen Li
Yanchen Li
QCQinhua Chen
Qinhua Chen
XPXiaoyan Pan
Xiaoyan Pan
WLWen Lu
Wen Lu
JZJie Zhang
Jie Zhang

1 October 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
TDTaoyan Dou
Taoyan Dou
JWJie Wang
Jie Wang
CHChengkun Han
Chengkun Han
XSXiaowei Shao
Xiaowei Shao
JZJie Zhang
Jie Zhang
WLWen Lu
Wen Lu

13 April 2021 in Drug Development Research
Verified
Journal Article
Open access
PDF file
YZYingzhuan Zhan
Yingzhuan Zhan
WTWenjing Ta
Wenjing Ta
WTWenjuan Tang
Wenjuan Tang
RHRuochen Hua
Ruochen Hua
JWJue Wang
Jue Wang
WLWen Lu
Wen Lu
Coronavirus Disease 2019 (COVID‐19) cases and deaths are still rising worldwide, there is currently no effective treatment for severe inflammation and acute lung injury caused by new coronavirus (SARS‐COV‐2) infection. Therapies to prevent or treat COVID‐19, including antiviral drug and several vaccines, are still being development. Human angiotensin‐converting enzyme 2 (ACE2), expressing in lung, has been confirmed to be a receptor for SARS‐COV‐2 infection, interventions for attachment of spike protein of SARS‐CoV‐2 to ACE2 may be a potential approach to prevent viral infections and it is considered as a potential target for drug development. In this study, we observed that seabuckthorn and its flavonoid compounds quercetin and isorhamnetin were shown strong retention to ACE2 overexpression HEK293 (ACE2h) cells by CMC analysis. Based on drug receptor interaction analysis and viral entry studies in vitro, we evaluated the interaction of two flavonoid compounds and ACE2 as well as the inhibitory effect of the two compounds on viral entry. Surface plasmon resonance assay proved the effect that isorhamnetin bound to the ACE2, and its affinity (KD value) was at the micromolar level, that was, 2.51 ± 0.68 μM. Viral entry studies in vitro indicated that isorhamnetin inhibited SARS‐CoV‐2 spike pseudotyped virus entering ACE2h cells. Based on promising in vitro results, we proposed isorhamnetin to be a potential therapeutic candidate compound against COVID‐19.

1 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
XLXingyue Li
Xingyue Li
WTWenjing Ta
Wenjing Ta
RHRuochen Hua
Ruochen Hua
JSJihong Song
Jihong Song
WLWen Lu
Wen Lu
Glioma is an invasive brain cancer, and it is difficult to achieve desired therapeutic effects due to the high postoperative recurrence rate and limited efficacy of drug therapy hindered by the biological barrier of brain tissue. Nanodrug delivery systems are of great interest, and many efforts have been made to utilize them for glioma treatment. Polyamidoamine (PAMAM), a starburst dendrimer, provides malleable molecular size, functionalized molecular structure and penetrable brain barrier characteristics. Therefore, PAMAM-based nanodrug delivery systems (PAMAM DDS) are preferred for glioma treatment research. In this review, experimental studies on PAMAM DDS for glioma therapy were focused on and summarized. Emphasis was given to three major topics: methods of drug loading, linkers between drug/ligand and PAMAM and ligands of modified PAMAM. A strategy for well-designed PAMAM DDS for glioma treatment was proposed. Purposefully understanding the physicochemical and structural characteristics of drugs is necessary for selecting drug loading methods and achieving high drug loading capacity. Additionally, functional ligands contribute to achieving the brain targeting, brain penetration and low toxicity of PAMAM DDS. Furthermore, a brilliant linker facilitates multidrug combination and multifunctional PAMAM DDS. PAMAM DDS show excellent promise as drug vehicles and will be further studied for product development and safety evaluation.

1 April 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
WTWenjing Ta
Wenjing Ta
XLXingyue Li
Xingyue Li
JSJihong Song
Jihong Song
RHRuochen Hua
Ruochen Hua
YZYuting Zheng
Yuting Zheng
WLWen Lu
Wen Lu
Purpose: Nanotechnology-based drug delivery systems (nano-DDS) have been developed to be a promising strategy to improve the efficacy, safety, physicochemical and pharmacokinetic/pharmacodynamics properties of drugs. It is very necessary to elucidate the delivery process in vivo or in cells for the rational design and accurate preparation of nano-DDS. The aim of this study was to construct a nano-DDS to visualize and quantify the intracellular behavior of the loaded cargo and carrier in such a system. Methods: A carboxyl-terminal end of poly(lactic-co-glycolic acid) polymer was fluorescently labeled with rhodamine B by conjugation of ethylenediamine. Dual-fluorescent nanoparticles (DFPs) were prepared from this fluorescently labeled polymer to encapsulate a fluorescent cargo, coumarin 6. The carrier and cargo of DFPs were monitored by confocal fluorescence microscopy during cellular uptake. Furthermore, the transcellular transportation of DFPs was evaluated quantitatively by measuring the fluorescence intensity. Results: The obtained fluorescent polymer showed stable and quantifiable characteristics. DFPs could be customized in terms of coumarin 6 content (97.7± 1.0%), size (367.3± 1.7 nm) and dual-emission fluorescence (green cargo and red carrier). DFPs did not significantly affect cell viability, the integrity of cell monolayers and the microscopic morphology at concentrations below 0.7 mg/mL within 3 h of co-incubation with Caco-2 cells. Multichannel fluorescence monitoring revealed that the fluorescence intensity of the carrier and cargo increased with time, but not synchronously. By calculating the residual, intracellular, and transport amounts of DFPs, the material balance between the total amount of cellular transport and the dose administered was obtained. Conclusion: Based on the advantages of dual fluorescent labeling, the differential behavior of cell trafficking can be visualized and quantitatively analyzed for the cargo and carrier of DFPs. These results provide insights into the cellular transport process of holistic nanoparticles and complement our understanding of the biological behaviors of nano-DDS.

29 September 2021 in Topics in Current Chemistry
Verified
Journal Article
Closed access
PDF file
ZLZilong Li
Zilong Li
QCQinhua Chen
Qinhua Chen
JWJin Wang
Jin Wang
XPXiaoyan Pan
Xiaoyan Pan
WLWen Lu
Wen Lu